Synonyms: MPC-9528 | MPI-485520
Compound class:
Synthetic organic
Comment: MPI-0485520 (MPC-9528) is a potent and highly selective small molecule inhibitor TBK1/ and IKKε. It is one of 80 structures claimed in Domainex's patent WO2012010826, where it is referred to as DMX-14 [1].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Immunopharmacology Comments |
MPI-0485520 is an oral anti-interferon candidate developed by Myrexis, Inc., for the treatment of autoimmune diseases. It suppresses production of IFN α/β and other pro-inflammatory cytokines involved in autoimmune disorders. |